Contact this trialFirst, we need to learn more about you.
Growth Factor
Stem Cell Mobilization for T Cell Lymphocytopenia
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing a combination of drugs to see if they can help people with a rare syndrome called idiopathic CD4 lymphocytopenia. The syndrome is defined by low CD4 T cell counts, which can leave patients at risk for opportunistic infections. The drugs being tested are granulocyte colony stimulating factor (G-CSF) and plerixafor. The trial will involve healthy volunteers and patients with the syndrome.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.